Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Humanigen (HGENQ)
OTHER OTC:HGENQ
Humanigen (HGENQ) Stock Price & Analysis
384 Followers
HGENQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.21
Previous Close$0.01
Volume2.00
Average Volume (3M)N/A
Market Cap
$797.84K
Enterprise Value-$2.30M
Total Cash (Recent Filing)$3.10M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)>-0.1
Beta2.72
Next Earnings
Nov 15, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding119,080,135
10 Day Avg. Volume28,933
30 Day Avg. VolumeN/A
Standard Deviation0.57
R-Squared0.01
Alpha-0.00145
Financial Highlights & Ratios
Price to Book (P/B)-0.02
Price to Sales (P/S)3.61
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.35
Enterprise Value/Gross Profit-0.91
Enterprise Value/Ebitda0.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
35.83% Insiders
1.80% Mutual Funds
0.01% Other Institutional Investors
62.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
HGENQ FAQ
What was Humanigen’s price range in the past 12 months?
Humanigen lowest stock price was <$0.01 and its highest was $0.21 in the past 12 months.
What is Humanigen’s market cap?
Currently, no data Available
When is Humanigen’s upcoming earnings report date?
Humanigen’s upcoming earnings report date is Nov 15, 2023 which is 165 days ago.
How were Humanigen’s earnings last quarter?
Currently, no data Available
Is Humanigen overvalued?
According to Wall Street analysts Humanigen’s price is currently Overvalued.
Does Humanigen pay dividends?
Humanigen does not currently pay dividends.
What is Humanigen’s EPS estimate?
Humanigen’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Humanigen have?
Humanigen has 119,080,130 shares outstanding.
What happened to Humanigen’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Humanigen?
Among the largest hedge funds holding Humanigen’s share is Sheaff Brock Investment Advisors LLC. It holds Humanigen’s shares valued at N/A.
---
Humanigen Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Humanigen
Humanigen, Inc. is a clinical-stage biopharmaceutical company. It engages in the developing next-generation cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Burlingame, CA.
---
HGENQ Stock 12 Months Forecast
Average Price Target
―---